You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Clinical lab supply firm Streck will exclusively supply Biodesix with DNA and RNA tubes, including its lines of blood collection tubes.
The companies will use their respective technologies to develop multiplex molecular diagnostic panels for laboratory testing.
Under the terms of the agreement, Natera will develop in vitro diagnostic products for oncology and pay Illumina milestone payments and royalties.
Seattle-based chemical manufacturer Arzeda will buy megabase quantities of synthetic DNA from Gen9 for use in developing new advanced molecules.
The supply agreement was originally established between BG and the now defunct Health Diagnostics Laboratory, which was formerly BG's biggest customer.
Norgen Biotek's sample prep products are already used in Biodesix's GeneStrat liquid biopsy assay workflow.
The two companies are extending an existing agreement that provides for PerkinElmer to supply Agilent with chips for its 2100 Bioanalyzer system.
The Madison, Wisconsin-based firm, a subsidiary of Fujifilm, will supply iCell products to Roche for use in drug discovery.
WaferGen's Apollo 324 NGS library preparation technology will be used for sequencing-based genetic testing in reproductive health.
The samples, which include non-small cell lung cancer samples, will be screened for cancer fusions, copy number variations, SNPs, and insertions and deletions.
Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.
The UK is implementing COVID-19 testing with a 90-minute turnaround time.
The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.
In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.